Limited supply, poor infra: The cold barriers to getting vaccinated in Asia

Some nations have signed on to procurement and advanced purchasing plans from vaccine manufacturers. Others are working on collaborations and homegrown options

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

McKinsey & Co. has said that just 1% of existing vaccine distribution networks is set up for cold-chain requirements that keep the new Covid-19 serums viable.

Anjani Trivedi | Bloomberg
Doctors, nurses and other essential workers are getting vaccinated against Covid-19 in the U.S. and U.K. Yet in Asia, where several countries led the way in reining in the viral outbreak, there are few signs that detailed distribution plans are ready to be implemented. Supplies are limited and unknowns plentiful. Governments need to jump-start the process to get shots into arms. In most cases, however, their capacity to distribute the vaccine is a constraint or simply doesn’t exist.

Some nations have signed on to procurement and advanced purchasing plans from vaccine manufacturers. Others are working on collaborations and homegrown options. But

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 21 2020 | 8:36 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com